Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)  
$29.04 0.53 (1.86%) as of 4:30 Wed 3/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 49,450,000
Market Cap: 1.44(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $26.32 - $47.5
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  623
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 119,323 119,323 208,796 351,548
Total Sell Value $3,656,226 $3,656,226 $7,121,778 $16,615,472
Total People Sold 1 1 15 17
Total Sell Transactions 3 3 37 64
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 257
  Page 7 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Evnin Luke Director   –       •      –    2013-04-12 4 AS $30.00 $300,000 I/I (10,000) 1,280,479     -
   Patou Gary Chief Medical Officer   •       –      –    2013-04-12 4 AS $30.00 $300,000 D/D (10,000) 0     -
   Patou Gary Chief Medical Officer   •       –      –    2013-04-12 4 OE $1.61 $16,100 D/D 10,000 10,000     -
   Wicki Andreas Director   –       •      –    2013-04-12 4 AS $30.00 $1,028,820 I/I (34,294) 2,199,099     -
   Wicki Andreas Director   –       •      –    2013-04-11 4 AS $30.00 $18,000 I/I (600) 2,233,393     -
   Patou Gary Chief Medical Officer   •       –      –    2013-04-01 4 AS $27.75 $844,591 D/D (30,000) 0     -
   Patou Gary Chief Medical Officer   •       –      –    2013-04-01 4 OE $1.61 $48,300 D/D 30,000 30,000     -
   Longenecker John P Phd Director   –       •      –    2013-03-28 4 AS $28.49 $56,980 D/D (2,000) 0     -
   Longenecker John P Phd Director   –       •      –    2013-03-28 4 OE $1.61 $3,220 D/D 2,000 2,000     -
   Stack David M President and CEO   •       •      –    2013-03-28 4 AS $28.66 $429,900 D/D (15,000) 2,573     -
   Stack David M President and CEO   •       •      –    2013-03-28 4 OE $1.61 $24,150 D/D 15,000 17,573     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-03-28 4 AS $28.49 $284,900 D/D (10,000) 5,000     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-03-28 4 OE $1.61 $16,100 D/D 10,000 15,000     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2013-03-25 4 AS $28.28 $4,680,738 D/D (165,541) 2,233,993     -
   Wicki Andreas Director   –       •      –    2013-03-25 4 AS $28.28 $4,680,738 I/I (165,541) 2,233,993     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2013-03-22 4 AS $27.52 $3,135,595 D/D (113,928) 2,399,534     -
   Wicki Andreas Director   –       •      –    2013-03-22 4 AS $27.52 $3,135,595 I/I (113,928) 2,399,534     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2013-03-21 4 AS $27.50 $314,353 D/D (11,431) 2,513,462     -
   Wicki Andreas Director   –       •      –    2013-03-21 4 AS $27.50 $314,353 I/I (11,431) 2,513,462     -
   Wicki Andreas Director   –       •      –    2013-03-19 4 AS $27.86 $253,501 I/I (9,100) 2,524,893     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2013-03-19 4 AS $27.86 $253,501 D/D (9,100) 2,524,893     -
   Middleton Fred A Director   –       •      –    2013-03-19 4 AS $26.95 $2,306,831 D/D (84,589) 416,083     -
   Stack David M President and CEO   •       •      –    2013-03-18 4 A $0.00 $0 D/D 573 2,573     -
   Wicki Andreas Director   –       •      –    2013-03-18 4 AS $28.19 $11,277,480 I/I (400,000) 2,533,993     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2013-03-18 4 AS $28.19 $11,277,480 D/D (400,000) 2,533,993     -

  257 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed